Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.615 AUD 0.82% Market Closed
Market Cap: 147.1m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Intrinsic Value

The intrinsic value of one OCC stock under the Base Case scenario is 0.472 AUD. Compared to the current market price of 0.615 AUD, Orthocell Ltd is Overvalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OCC Intrinsic Value
0.472 AUD
Overvaluation 23%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Orthocell Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OCC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OCC?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Orthocell Ltd

Provide an overview of the primary business activities
of Orthocell Ltd.

What unique competitive advantages
does Orthocell Ltd hold over its rivals?

What risks and challenges
does Orthocell Ltd face in the near future?

Has there been any significant insider trading activity
in Orthocell Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Orthocell Ltd.

Provide P/S
for Orthocell Ltd.

Provide P/E
for Orthocell Ltd.

Provide P/OCF
for Orthocell Ltd.

Provide P/FCFE
for Orthocell Ltd.

Provide P/B
for Orthocell Ltd.

Provide EV/S
for Orthocell Ltd.

Provide EV/GP
for Orthocell Ltd.

Provide EV/EBITDA
for Orthocell Ltd.

Provide EV/EBIT
for Orthocell Ltd.

Provide EV/OCF
for Orthocell Ltd.

Provide EV/FCFF
for Orthocell Ltd.

Provide EV/IC
for Orthocell Ltd.

Show me price targets
for Orthocell Ltd made by professional analysts.

What are the Revenue projections
for Orthocell Ltd?

How accurate were the past Revenue estimates
for Orthocell Ltd?

What are the Net Income projections
for Orthocell Ltd?

How accurate were the past Net Income estimates
for Orthocell Ltd?

What are the EPS projections
for Orthocell Ltd?

How accurate were the past EPS estimates
for Orthocell Ltd?

What are the EBIT projections
for Orthocell Ltd?

How accurate were the past EBIT estimates
for Orthocell Ltd?

Compare the revenue forecasts
for Orthocell Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Orthocell Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Orthocell Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Orthocell Ltd compared to its peers.

Compare the P/E ratios
of Orthocell Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Orthocell Ltd with its peers.

Analyze the financial leverage
of Orthocell Ltd compared to its main competitors.

Show all profitability ratios
for Orthocell Ltd.

Provide ROE
for Orthocell Ltd.

Provide ROA
for Orthocell Ltd.

Provide ROIC
for Orthocell Ltd.

Provide ROCE
for Orthocell Ltd.

Provide Gross Margin
for Orthocell Ltd.

Provide Operating Margin
for Orthocell Ltd.

Provide Net Margin
for Orthocell Ltd.

Provide FCF Margin
for Orthocell Ltd.

Show all solvency ratios
for Orthocell Ltd.

Provide D/E Ratio
for Orthocell Ltd.

Provide D/A Ratio
for Orthocell Ltd.

Provide Interest Coverage Ratio
for Orthocell Ltd.

Provide Altman Z-Score Ratio
for Orthocell Ltd.

Provide Quick Ratio
for Orthocell Ltd.

Provide Current Ratio
for Orthocell Ltd.

Provide Cash Ratio
for Orthocell Ltd.

What is the historical Revenue growth
over the last 5 years for Orthocell Ltd?

What is the historical Net Income growth
over the last 5 years for Orthocell Ltd?

What is the current Free Cash Flow
of Orthocell Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Orthocell Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Orthocell Ltd

Current Assets 23m
Cash & Short-Term Investments 20.6m
Receivables 1.2m
Other Current Assets 1.2m
Non-Current Assets 3.6m
PP&E 2.6m
Intangibles 1m
Other Non-Current Assets -10
Current Liabilities 5.3m
Accounts Payable 1.5m
Accrued Liabilities 1.4m
Other Current Liabilities 2.5m
Non-Current Liabilities 16.8m
Long-Term Debt 540.7k
Other Non-Current Liabilities 16.2m
Efficiency

Earnings Waterfall
Orthocell Ltd

Revenue
6.8m AUD
Cost of Revenue
-1.6m AUD
Gross Profit
5.1m AUD
Operating Expenses
-15.4m AUD
Operating Income
-10.2m AUD
Other Expenses
3.1m AUD
Net Income
-7.2m AUD

Free Cash Flow Analysis
Orthocell Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

OCC Profitability Score
Profitability Due Diligence

Orthocell Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Exceptional 1-Year Revenue Growth
29/100
Profitability
Score

Orthocell Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

OCC Solvency Score
Solvency Due Diligence

Orthocell Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Negative Net Debt
Low D/E
72/100
Solvency
Score

Orthocell Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCC Price Targets Summary
Orthocell Ltd

Wall Street analysts forecast OCC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCC is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.

Lowest
Price Target
0.556 AUD
10% Downside
Average
Price Target
0.561 AUD
9% Downside
Highest
Price Target
0.578 AUD
6% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OCC?

Click here to dive deeper.

Dividends

Orthocell Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for OCC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

OCC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Orthocell Ltd Logo
Orthocell Ltd

Country

Australia

Industry

Biotechnology

Market Cap

147.1m AUD

Dividend Yield

0%

Description

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is engaged in the development and commercialization of cell therapies and biological medical devices. The firm offers two main products, including CelGro and Ortho-ATI. CelGro is a naturally derived collagen medical device, which is designed for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons and cartilage. The company represents a paradigm shift in bone and soft tissue reconstruction. Ortho-ATI is a cell therapy for treatment of chronic tendon injuries. The treatment uses patient’s own tendon-derived cells to stimulate tendon regeneration and is delivered via a non-surgical ultrasound guided injection. The firm has a Good Manufacturing Process (GMP) facility. The facility is licensed by the Therapeutic Goods Administration (TGA) for the manufacture of human tendon cells and cartilage cells for the regeneration of damaged tendon and cartilage.

Contact

WESTERN AUSTRALIA
Perth
Building 191 Murdoch University, South Street Murdoch
+61893602888.0
www.orthocell.com.au

IPO

2014-08-12

Employees

-

Officers

CEO, MD & Executive Director
Mr. Paul Frederick Anderson
Chief Financial Officer
Ms. Nicole Jane Telford
Chief Operating Officer
Mr. Alex McHenry
Chief Scientific Officer and Member of Medical & Scientific Advisory Board
Prof. Ming Hao Zheng
Chief Technical Operations Officer
Mr. Tony Macintyre
Chief Commercial Officer
Mr. Vik Malik
Show More
Company Secretary
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one OCC stock?

The intrinsic value of one OCC stock under the Base Case scenario is 0.472 AUD.

Is OCC stock undervalued or overvalued?

Compared to the current market price of 0.615 AUD, Orthocell Ltd is Overvalued by 23%.

Back to Top